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ABSTRACT  
Purpose. The purpose of this study was to examine the effects of chronic L-carnitine and 
carbohydrate supplementation on body composition, perceived exertion, and athletic 
performance in recreationally-trained female endurance runners. Methods. On three separate 
occasions, twenty-one days a part, seven recreationally-trained female endurance runners 
performed a timed progressive treadmill test to exhaustion as well as a body composition 
assessment using the Bod Pod. Participants were randomly assigned to one of two groups – L-
carnitine (LC) or L-carnitine plus carbohydrates (LC + CHO). The LC group consumed 2 g of L-
carnitine L-tartrate and the LC + CHO group consumed 2 g of L-carnitine L-tartrate with 10 g of 
flavorless dextrose powder. Rating of perceived exertion, time to fatigue, and body composition 
was recorded during each of the three visits. Results. The results of this study revealed no 
significant interactions or main effects for time and treatment (p = .11). In addition, no 
significant differences were seen between subjects for body composition (%FFM p = .54; FFM p 
= .17; FM p = .75; %FM p = .57) or RPE (p = .95). Conclusion. In conclusion, this study 
demonstrated that chronic carnitine and carbohydrate feeding likely does not influence RPE, 
time to fatigue, or body composition in recreational endurance-trained female runners.  
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CHAPTER 1 
INTRODUCTION 
Carnitine, a nonprotein amino acid, is found naturally in the body, mainly in the muscles, 
and is synthesized from the amino acids lysine and methionine (Orer & Guzel, 2014). Not only is 
it found naturally in the body, but L-Carnitine (LC) can be found in numerous dietary food 
sources including red meats and dairy, and in smaller amounts in fish, poultry, asparagus, 
tempeh, and peanut butter. Carnitine can also be found as a supplement in various forms, 
including Acetyl L-Carnitine, Propionyl-L-Carnitine, and the most widely available, L-Carnitine 
(Carnitine Shuttle; Ehrlich, 2014). Carnitine is necessary for the important role of shuttling fatty 
acids, specifically long-chain fatty acids, across the inner mitochondrial membrane for beta-
oxidation (Karahan, Coksevim & Artis, 2010). This transport system is the critical rate-limiting 
step for beta-oxidation. Thus, if this transport system is continuously in motion, beta-oxidation 
will occur at a normal rate, allowing the fatty acid molecules to be broken down in the 
mitochondria to generate acetyl-CoA, and eventually ATP. 
Carnitine supplementation has become increasingly popular over the years, claiming to 
promote fat loss, increase energy, and help prevent an increase in body fat mass. However, the 
benefit of carnitine supplementation in individuals without deficiency is widely up for debate 
(Watcher et al., 2002). Until recently, few researchers have found significant evidence that 
substantiates carnitine feeding to enhance athletic performance. Nevertheless, research now 
supports evidence that carnitine supplementation, in combination with carbohydrates (CHO), can 
produce ergogenic effects in individuals without deficiency (Broad et al., 2011; Stephens et al., 
2013; Wall et al., 2011). 
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As previously mentioned, one of the major claims associated with L-carnitine 
supplementation is its potential “fat burning” capability, however, research associated with 
carnitine supplementation and fat loss is limited and some studies do not support the use the LC 
for fat loss purposes. For instance, Kruszewski (2011) examined changes in maximal strength 
and body composition after the ingestion of creatine, L-carnitine, or β-hydroxy-β-methylbutyrate 
(HMB) among novice male body builders with little to no training experience. Participants in the 
carnitine group consumed either an L-carnitine supplement or placebo, both at 900 mg per day 
for a total of 1.2 months. Over that time period, participants were instructed to perform circuit 
training-like exercise three times a week at the same time each day. Bioelectrical impedance 
analysis (BIA) was then used to determine fat and water content in the body. Results showed no 
significant changes in fat or water content in the LC group, as well as no significant changes in 
body mass. These findings do not support the claims currently made by supplement companies, 
in that carnitine supplementation did not have a significant effect on body composition in these 
subjects.  
Similarly, Wutzke and Lornez (2004) examined the effect of L-carnitine on fat oxidation, 
protein turnover, and body composition in twelve slightly overweight participants (7 females, 5 
males; age 18 to 30 years). Participants in the study had kept their weight stable for at least one 
month prior to the start of the study. For twenty days, participants were provided with a regular, 
individualized diet either with or without 3 g of carnitine per day (10 days with LC, 10 days 
without). In order to assess protein turnover, an algae lipid mixture was given to participants 
simultaneously on the ninth day. Urine samples were collected at different intervals over a period 
of 36 hours after administration of the mixture. In addition, BIA was used to determine body fat 
mass (BFM), total body water (TBW), lean body mass (LBM), and body weight (BW). In this 
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population, results showed no change in BFM (21.3  4.8 vs 21.5  5.1 kg), LBM (58.1  10.8 
vs 58.3  10.6 kg) TBW (42.5  7.9 vs 42.7  7.8 L), and BW (79.4  10.5 vs 79.7  11.5 kg) at 
the end of the supplementation period. Once more, few studies have been able to support the use 
of carnitine supplementation in preventing body fat accumulation, therefore more research is 
necessary to substantiate this claim.  
Other interests in carnitine spur from the claim that supplementation has the potential to 
improve athletic performance due to carnitine’s role in energy metabolism. Through the carnitine 
transport system, fatty acids are able to enter the mitochondria to be broken down for subsequent 
-oxidation, specifically during endurance exercise, where the reliance of fatty acids as a fuel 
source becomes higher. Watcher, Vogt, & Kreis (2002) investigated the effects of long-term L-
carnitine supplementation on skeletal muscle carnitine content and physical performance in eight 
healthy male adults. Using a cycle ergometer, participants exercised for 10 minutes at 20%, 40%, 
and 60% of their individual maximal workload (Pmax) until exhaustion. Afterwards, participants 
were instructed to consume 2 g of LC two times per day for 3 months. Exercise tests and muscle 
biopsies were performed before, immediately after, and two months after the treatment. Results 
of the study revealed no significant changes in VO2, RER, blood lactate concentrations, or heart 
rate when compared to pretreatment values after 3 months of LC supplementation. In addition, a 
5% increase was seen in VO2 at submaximal workloads (40% and 60% of Pmax) when compared 
to pretreatment values, however, VO2max, HR, VO2 at 20% Pmax, RER, and blood lactate 
concentrations were not significantly different from values obtained before the treatment.  
Furthermore, recent research has reported that ingestion of L-carnitine in combination 
with carbohydrates has been shown to prolong exercise endurance as well as aid in the recovery 
of muscles post-exercise. Wall, Stephens, & Constantin-Teodosiu (2011) examined muscle 
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carnitine content and alterations in muscle fuel metabolism during exercise in fourteen 
moderately trained athletes. On three separate occasions, participants reported to the lab to 
complete a 60-minute cycling test for 30 minutes at 50%, followed immediately by 30 minutes at 
80% of their predetermined VO2max.  Rating of perceived exertion (RPE) was recorded every ten 
minutes. After the first visit, participants were separated into either a control (80 g orange-
flavored CHO polymer) or carnitine group (80 g orange-flavored CHO polymer plus 1.36 g of 
LC). Blood samples and muscle biopsies were taken on each visit to examine plasma total 
carnitine (TC) concentration and muscle free carnitine, acetylcarnitine, and long-chain 
acylcarnitine. After 24 weeks of supplementation, results of the study revealed higher plasma TC 
concentrations after 12 and 24 weeks in the carnitine group when compared with control, and a 
35% decrease in muscle glycogen content after exercise at 50% VO2max. In addition, after 
exercise of 80% VO2max, a 44% decrease was seen in muscle lactate content in the carnitine 
group compared to control. Work output also increased by 11% from baseline after 24 weeks, 
35% greater compared to control. These findings are the first to show that carnitine 
concentrations in the muscle can be increased through dietary means and may be exercise-
intensity dependent. Wall and colleagues (2011) also demonstrated that at lower intensities (50% 
VO2max), increasing muscle carnitine content spares muscle glycogen, thus utilizing lipids as a 
fuel source.  
Various limitations and inconsistencies exist in current literature involving carnitine 
supplementation. Research involving carnitine supplementation has produced conflicting results, 
probably due to small sample sizes, inconsistent duration of supplementation, and the use of 
mainly male participants. For example, Broad et al. (2011) examined L-Carnitine L-Tartrate 
(LCLT) supplementation on sixteen endurance-trained male athletes over a 15-day period and 
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found significant differences in mean exercise heart rate (HR) and rating of perceived exertion 
when participants performed an exercise test on a cycle ergometer at varying intensities. 
Similarly, Mustafa, Beker, & Artis (2010) found that ten days of carnitine supplementation in 
twenty male, well-trained athletes produced significant changes in 1500m running performance 
time and plasma lactate levels in their control group (fruit juice) compared with the carnitine 
group (2 g/day LCLT mixed with fruit juice). In addition, Swart, Rossouw, & Loots (1997) 
found significant differences in running speed (5.68% increase from baseline), heart rate, and 
respiratory exchange ratio when examining the effect of L-carnitine supplementation on plasma 
carnitine levels and different performance parameters in seven male marathon athletes over a 
period of six weeks. Participants performed two progressive treadmill tests to exhaustion, and 
results of the study showed a 5.68% increase in running speed, as well as a decrease in oxygen 
consumption and heart rate when compared to baseline.  
In addition to inconsistent sample size and length of supplementation, most studies use 
predominantly male or mixed gender samples, whereas few studies have used exclusively female 
samples. Within the last few decades, important differences in exercise capacity between males 
and females has been brought to light (Sheel, Richards, Foster, & Guenette, 2004). For instance, 
compared to males, females tend to utilize more lipid and less carbohydrate for energy during 
endurance exercise. In addition, fatigability of skeletal muscle appears to be different when 
comparing genders, which could be related to differences in muscle mass, substrate utilization, 
and recovery (Sheel, Richards, Foster, & Guenette, 2004). Howden, Perhonen, & Peshock (2015) 
examined the effect of cardiovascular response to one year of intensive endurance training on 
previously untrained males and females, matched for training volume and intensity. Each 
participant underwent various tests every three months to assess body composition as well as 
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VO2max, left ventricle mass (LV), and cardiac magnetic resonance imaging (MRI) testing. Results 
of the study found that compared to males, female participants had a lower percentage of fat free 
mass (FFM) and lower hematocrit levels before training. However, upon completion of the study 
protocol, there were no significant differences between sexes for hematocrit, body fat, and 
indexed blood volume. Furthermore, VO2max was increased in both sexes (22% in males, 15% in 
females), but VO2max response was blunted after three months in female participants compared to 
males. In the female population, VO2max, LV mass, and mean wall thickness plateaued after 3 
months of training, whereas those same measures increased in male participants before 
plateauing in months 9-12. As mentioned in the study, one reason for the plateau in exercise 
performance in the female population may be related to the groups suboptimal energy intake, as 
the study protocol only provided general dietary advice (Howden, Perhonen, & Peshock, 2015). 
This study is one example of the different physiological responses to exercise between males and 
females. Other factors that may have contributed to the lack of training effect in exercise 
performance include hormonal and environmental factors (Howden, Perhonen, & Peshock, 
2015).  
Likewise, an important factor to consider when working with the female population and 
exercise is the use of oral contraceptives. Joyce, Sabapathy, Bulmer, & Minahan (2013) 
examined the effect of long-term oral contraceptive use on the endurance performance of 
recreationally active women. Plasma ethanol estradiol, a hormone found in many oral 
contraceptives, inhibits the production of the hormone 17 B-estradiol, and appears six times 
higher in individuals taking oral contraceptives than those that do not. For this study, participants 
were separated into two groups: oral contraceptive (OC) and those who were not using oral 
contraceptives (CON). Baseline samples were then taken to assess levels of 17 B-estradiol and 
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progesterone. VO2peak and anaerobic threshold (AT) were measured using a cycle ergometer 
where participants completed various exercise tests to exhaustion. Heart rate (HR), RPE, 
pulmonary gas exchange, blood lactate concentration (La) and time to exhaustion were assessed 
during the tests. Significant differences were observed in VO2peak and VO2 at AT in the CON 
group when compared to the OC group. However, HR, BP, and La concentrations were not 
significantly different between the groups. Results of this study propose that long-term use of 
oral contraceptives negatively affect VO2peak and VO2 at AT, but have no effect on athletic 
performance in recreationally trained female endurance runners.   
Overall, the importance of the current study lies in the fact that few researchers have been 
able to produce consistent results with LC supplementation and studies involving carnitine and 
CHO supplementation are relatively novel. The current study set out to examine the effect of 
chronic L-carnitine and carbohydrate feeding on overall on body composition and athletic 
performance in female recreational endurance runners. Chronic carnitine and CHO 
supplementation (> 4 weeks) has given promising insight into changes in fuel metabolism and 
recovery after exercise. It was hypothesized that participants receiving the CHO + LC would 
have a significantly higher work output and would have lower feelings of fatigue when compared 
to LC group. In addition, it was hypothesized that participants receiving the CHO + carnitine 
supplement will see no increase in fat mass when compared to LC group. 
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Purpose Statement: 
The purpose of this study was to examine the effects of chronic L-carnitine and carbohydrate 
supplementation on body composition, perceived exertion, and athletic performance in female 
endurance athletes. 
Hypotheses: 
1. Subjects receiving the CHO + carnitine supplement will have a significantly higher work 
output when compared to the LC group. 
2. Subjects receiving the CHO + carnitine supplement will have lower feelings of fatigue 
when compared to LC group.  
3. Subjects receiving the CHO + carnitine supplement will see no increase in fat mass when 
compared to LC group. 
Research Questions: 
 
1. Does chronic carnitine and CHO feeding increase work output? 
2. Does chronic carnitine and CHO feeding reduce the feeling of fatigue? 
3. Does chronic carnitine and CHO feeding prevent increases in body fat mass? 
Rationale: 
Previous research has produced conflicting results when it comes to L-carnitine (LC) 
supplementation and its effect on athletic performance. The importance of this study lies in the 
fact that few researchers have been able to produce consistent results with LC supplementation 
and, furthermore, studies involving LC and carbohydrate (CHO) supplementation are relatively 
modern. Thus far, chronic LC and CHO supplementation (> 4 weeks) has given a promising 
insight into enhancing athletic performance by reducing the physiological effects of exercise and 
improving recovery. Currently, many studies have been unable to support the use of carnitine 
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supplementation to enhance athletic performance, however these conclusions have been drawn 
based on small numbers of participants, short duration of supplementation, lack of appropriate 
control groups (Higdon, 2002), type of supplementation, or control of diet before exercise 
(Abramowicz & Galloway, 2005), so further research is necessary in this area. Therefore, the 
purpose of this study was to examine the effect of chronic L-carnitine and carbohydrate feeding 
on athletic performance, body composition, and perceived exertion in female endurance athletes.  
 
Limitations: 
• Random assignment of supplement groups (carbohydrate + L-carnitine or L-carnitine) 
• Inability to collect blood samples for analysis 
•  Small sample size 
• Not regulating menstrual cycle 
• Spring Break fell in the middle of the study protocol, postponing testing for some of the 
participants.  
• Other limitations to this study included possible threats to internal and external validity 
including history of gastrointestinal or metabolic disorders, mortality, maturation, testing 
and instrumentation, as well as the reactive or interaction effect of testing. 
Delimitations: 
Participants for this study consisted of recreationally active females, ages 19-22 years, who were 
participating in at least 150 minutes of endurance exercise a week. Participants were familiar 
with the addition of CHO supplements in their dietary regimen and were not taking any 
performance enhancing drugs or any medications that may affect body composition or appetite. 
Participants ceased any additional supplementation regimen for the duration of the study and 
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maintained their training regimen and diet. Participants also must have been taking oral 
contraceptives for at least six months prior to the first trial.  
 
Assumptions: 
1. Participants will return for all required exercise protocols. 
2. Participants will take their required dosages of the supplement they are given.  
3. Participants will take their required supplements at the correct time and frequency 
throughout the study. 
4. Participants will not be taking any performance enhancing drugs at the time of the study 
5. Participants will continue with their current diet and training regimen throughout the 
duration of the study 
6. The Bod Pod® is a reliable and valid measure of body composition 
7. The ParvoMedics TrueOne® 2400 proves to be an accurate and reliable device for the 
measurement of gas exchange variables 
Operational Definitions: 
 
1. Exhaustion: A state of extreme physical or mental fatigue 
2. Carnitine: An amino acid derived from the amino acids, lysine and methionine. Carnitine 
plays a crucial role in the transport of fatty acids into the mitochondria.  
3. VO2peak: Also known as maximal oxygen uptake; refers to the maximum amount of 
oxygen that an individual can utilize during intense or maximal exercise. VO2max is one of 
many factors that can help predict an athlete's ability to perform sustained exercise.  
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CHAPTER 2 
LITERATURE REVIEW 
Carnitine in the Human Body 
L-Carnitine is just one of the many critical components involved in the metabolic process 
of beta-oxidation. The most widely researched aspect, and primary function, of this amino acid-
like substance is its role in the transportation of long-chain fatty acids (LCFAs) across the inner 
mitochondrial membrane (Karlic & Lohninger, 2004) for use as fuel by the body. With the main 
sites for carnitine storage being cardiac and skeletal muscle (Higdon, 2002), carnitine also acts as 
a buffer for excess acetyl-CoA in the muscle that accumulates during exercise (Broad, Maughan 
& Galloway, 2005).  This buffering mechanism is thought to relieve the inhibition of the 
pyruvate dehydrogenase enzyme complex (PDC), which in turn increases glycolytic flux during 
exercise (Broad et al., 2005). The main sites for carnitine synthesis include the liver and kidney, 
where carnitine can then be transported to other tissues in the body.  
Two main enzymes - carnitine palmitoyltransferase I (CPT I) and carnitine 
palmitoyltransferase II (CPT II) - make up the carnitine palmitoyltransferase system that is 
involved in initiating the transport of LCFAs into the mitochondria (Carnitine Shuttle). In order 
for L-carnitine to enter the mitochondrial matrix, it must first be in the form of an ester, 
acylcarnitine (Higdon, 2002). CPT I, the rate limiting step in fatty acid oxidation, will then 
enable the transfer of the long-chain fatty acids into the cytosol from coenzyme-A (CoA) to L-
carnitine (Higdon, 2002). Once the carnitine is in the matrix, CPT II exchanges CoA for carnitine 
to produce fatty-acid CoA, which is then ready to enter fatty oxidation once more to produce 
energy, and the free carnitine is released back into the system to repeat the process (Carnitine 
shuttle).  
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Current studies have produced conflicting results as to whether endurance athletes need 
carnitine supplementation. For example, Broad and colleagues (2006) examined the dietary 
carnitine intake and carnitine status of endurance-trained males. Researchers recruited 14 non-
vegetarian endurance-trained males (ages 18-50 years), all of which completed a seven-day 
weighed food record and exercise record prior to the study to determine habitual carnitine intake. 
Resting blood samples and urine analyses were used to determine plasma carnitine 
concentrations and carnitine excretion in the urine. Researchers found that there were no 
correlations between dietary carnitine intake and 1) plasma carnitine concentrations (r = 0.13, p 
= 0.68) 2) free carnitine concentrations (0.36, p = 0.23) 3) acyl carnitine concentrations (−0.21, p 
= 0.50) or 4) urinary carnitine excretion (total − 0.05, p = 0.87; free 0.07, p = 0.81; acyl −0.16, p 
= 0.58). The dietary records of the endurance athletes, along with the results of the study, 
conclude that the carnitine levels of the subjects were comparable to normal adult levels and no 
dietary insufficiencies were present. Furthermore, no correlation could be noted between dietary 
carnitine intake, dietary macro- or micronutrients, and plasma carnitine or urinary carnitine 
excretion, indicating the subjects were not at risk for a carnitine deficiency.   
Carnitine Metabolism during Exercise 
In a fed state, the liver is both an organ of glucose uptake and fat oxidation, the latter 
converting glucose to LCFAs, which can then be either stored in the liver or transported to other 
tissues (Foster, 2006). However, in a fasted state, these metabolic pathways are essentially 
reversed. In a fasted state, the glucose production and fatty acid synthesis in the liver cease, and 
fatty acid oxidation begins to take form. This mechanism is one way of providing a defense 
against muscle protein catabolism (Foster, 2006). 
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Muscle fuel selection is an important factor to consider when it comes to exercise and 
carnitine supplementation. Two major substrates available for energy during exercise include fat 
and carbohydrates. Under high-intensity, submaximal conditions (> 70% VO2max), the body will 
utilize mainly muscle glycogen stores for fuel; however, these stores are relatively small 
compared to fat stores (Wall et al., 2013). Studies suggest that exercise at lower intensities (55-
70% VO2max) will enhance fat oxidation to its maximum potential in endurance-trained athletes 
(Achten et al., 2002). Optimizing the use of endogenous fat is an important factor to consider 
during endurance exercise as it may spare muscle glycogen stores (Wall et al., 2013).   
One study by Hottenrott and colleagues (2012) examined the effects of high-intensity 
training vs. endurance training on aerobic power and body composition in 34 recreationally 
active men and women. Participants were randomly separated into two groups - 1) weekend 
group (WE), who performed two sessions of continuous endurance exercise training on the 
weekend, and 2) after-work-group (AW), who performed four high-intensity training sessions 
and an additional endurance run during the week, after work. Pre-and post-tests included heart 
rate monitoring, body composition (total body fat, total muscle mass, visceral fat), and a fitness 
assessment for cardiovascular health (VOpeak). For the 12-week intervention, the WE group 
performed 2 h 30 min of continuous endurance running, and AW performed four 30 min sessions 
of high intensity training and an additional 30 min endurance run. After the 12-week 
intervention, subjects then competed in a half marathon.  Results of the study found significant 
decreases in both heart rate and body mass in both groups (WE and AW), however the AW 
group did not produce significant losses in fat free mass (p = 0.27) or total body mass, but there 
were significant decreases in total body mass, visceral fat (6.5%), and fat free mass in the WE 
group. Furthermore, both groups (AW and WE) significantly increased aerobic power (p = 0.01) 
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after the intervention, however, differences between groups were not observed. Overall, all 
subjects completed the half marathon after the 12-week intervention. This study suggests that 
both high-intensity and endurance exercise have the ability to improve aerobic capacity as well 
as body composition in recreationally trained men and women.  
In addition, exercise modality plays an important role in ventilatory patterns. Generally, 
the metabolic demands of exercise depend highly on the mode, as well as the amount of muscle 
mass recruited to perform the action (Tanner, Joseph, & Stager, 2014). To date, research 
examining ventilatory strategies used during cycle ergometry and treadmill running are scarce. In 
a study by Tanner and colleagues (2014), twenty-two healthy, trained men (age 23.6  5.7 years) 
were recruited to perform two maximal exercise tests in different modes, running and cycling. 
Participants were actively involved in running, cycling, or both, and were free of any 
cardiovascular or pulmonary disorders. On two separate testing occasions, participants reported 
to the lab 4 hours post-prandial, with two days in between each testing session. Each session 
consisted of a continuous, incremental exercise bout of running on a treadmill or cycling on an 
ergometer to determine maximal aerobic capacity.  
Furthermore, Smith and colleagues (2008) examined the effects of glycine propionyl-L-
carnitine on aerobic and anaerobic performance in 43 untrained men and women (ages 18-44). 
Participants performed a graded exercise test (GXT) on a motorized treadmill where expired 
gases were collected and VO2peak and anaerobic threshold were determined. Researchers also 
monitored blood pressure, heart rate, respiratory-exchange ratio (RER), and perceived exertion 
(Borg Scale) during the GXT. Anaerobic testing consisted of participants performing a 30-s 
cycle sprint test on a stationary cycle ergometer attached to a computer. During testing, peak and 
mean power relative to lean body mass were recorded as well as fatigue rate, and total work 
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relative to lean body mass. All participants performed the same tests but on different days. 
Following the pre-intervention tests - in a randomized, double blind manner - participants were 
assigned to one of three conditions: Placebo (1 g cellulose), GPLC-1 (348 mg glycine + PLC at 1 
g/day), or GPLC-3 (1,044 mg glycine + PLC at 3 g/day). Participants ingested three capsules two 
times per day for 8 weeks, then completed an identical post-intervention testing protocol. No 
significant differences (P > 0.05) were identified between or within the three groups for free, 
total, or acyl carnitine concentrations, or any of the performance variables. These findings 
suggest that GPLC supplementation has little, if any, effect on improving aerobic or anaerobic 
performance in untrained men and women more than aerobic exercise alone. 
During physical exercise, the ratio of carnitine pools in the body is constantly shifting 
between various body compartments, due mainly to the esterification of the free carnitine within 
the muscle pool with various acyl groups (Swart, Rossouw, Loots, & Kruger, 1997). Research 
suggests that endurance exercise may reduce these carnitine pools in the skeletal muscle and a 
carnitine deficiency may ensue - carnitine supplementation attenuating this process (Swart et al., 
1997). For example, Swart and colleagues (1997) examined the effect of L-carnitine 
supplementation on plasma carnitine levels and various performance parameters of seven male 
marathon athletes (age 27 ± 3 years). Each participant served as their own control, completing 
two progressive treadmill tests to exhaustion (0° gradient) separated by six weeks. Heart rate, 
oxygen consumption, and RER were measured during the test, and blood samples were drawn 
afterwards to determine the total carnitine (TC), free carnitine (FC), and average carnitine (AC) 
levels in the blood. Significant increases were found in the mean levels of TC and FC 
concentrations (p < 0.05) after L-carnitine supplementation and researchers saw a 5.68% average 
increase in peak treadmill running speed. Furthermore, subjects were able to maintain a higher 
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peak running speed, at a lower rate of O2 consumption after the carnitine supplementation, and 
RER significantly decreased as well. Further research is needed but these findings support 
carnitine supplementation and its ability to enhance overall running performance and aerobic 
capacity. 
Carnitine and Carbohydrate (CHO) Supplementation 
The American College of Sports Medicine (ACSM) recognizes carbohydrate 
supplementation as an important aspect of an athlete’s training and nutrition program. ACSM 
guidelines recommend that endurance athletes consume 2-3 grams of CHO/kg of body weight 
three to four hours prior to exercise, and fuel every 40-60 minutes. Furthermore, the effect of 
CHO on performance depends greatly on the duration and intensity of the event, as well as the 
training status of the athlete, the type of CHO, and the mode of exercise (Stellingwerff & Cox, 
2014).  There are various mechanisms that exist to explain the role of CHO and preventing 
fatigue, one being an oral stimulation of the central nervous system (CNS) (Stellingwerff & Cox, 
2014). For example, CHO can attenuate the effects of fatigue via a direct energy contribution 
from CHO oxidation during longer endurance events, as muscle glycogen stores became 
depleted more quickly (Stellingwerff & Cox, 2014). Furthermore, research has shown that CHO 
supplements have provided a higher benefit to athletes compared to ingesting water alone 
(Jeukendrup, 2010).  
Smith and colleagues (2010) examined glucose ingestion (15, 30, and 60 g/h) on 
endurance performance and fuel selection in 12 recreational healthy male cyclists. Peak VO2 and 
onset of blood lactate accumulation (OBLA) were assessed before testing began. Subjects 
completed a 2-h cycling exercise at 95% OBLA followed by a simulated 20-km time trial. 
Subjects completed four exercise trials - ingesting 2,000 mL of one of four beverages during 
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each 2-h ride - each separated by at least seven days. Researchers found that compared to 
placebo, significant increases were seen in the time trial mean power output by 7.4%, 8.3%, and 
10.7% for 15, 30, and 60 g/h, respectively.  
A similar example demonstrating the positive effects of CHO on endurance performance 
was in another study by Smith and colleagues (2013) where the dose-response relationship of 
CHO and performance was observed. Fifty-one recreationally trained, healthy male cyclists or 
triathletes (age 28.4 ± 6.7 years) were recruited for this study. Preliminary testing was used to 
determine VO2peak and onset of blood lactate accumulation (OBLA). Subjects performed an 
incremental cycling protocol consisting of a 2-h constant load ride at 95% OBLA, immediately 
followed by a 20-km time trial on their own bicycles stationed to a bicycle trainer. During four 
randomized trials, with 7 days in between each trial, subjects consumed 2,000 mL of 1 of 13 
beverages (ranging from 0% - 12% CHO) and electrolytes. Beverages were consumed every 15 
minutes in 250-mL portions. Results of the study were able to show that cycling at a VO2peak of 
~70%, along with the ingestion of a CHO beverage, significantly improved cycling performance 
compared to placebo during a 20-km cycling time trial. Furthermore, improvements in 
performance of 1.0%, 2.0%, 3.0%, 4.0%, and 4.7% were seen at 9, 19, 31, 48, and 78 g/h 
respectively, with 78 g/h eliciting the greatest response, as performance enhancement diminished 
at levels > 78 g/h. In conclusion, this study was able to demonstrate that CHO supplementation 
during prolonged exercise durations appear to enhance athletic performance in a curvilinear 
dose-response manner.  
More recently, researchers have begun to look at the effects of carnitine on glucose 
tolerance and insulin sensitivity. Researchers believe that the mechanisms in which carnitine acts 
on glucose metabolism requires the action of various contributing factors - 1) enhancement of 
  
22 
mitochondrial oxidation of long-chain acyl-CoAs 2) modulating the activity of the pyruvate 
dehydrogenase complex (PDHC) and the intramitochondrial acetyl-CoA/CoA ratio and 3) 
altering the expression of glycolytic and gluconeogenic enzymes to name a few (Ringseis, 
Keller, & Eder, 2012). Current research supports the notion that an accumulation of long-chain 
acyl-CoAs, as well as other fatty acid metabolites, impairs insulin signaling, therefore, 
contributing to the increased insulin resistance in the skeletal muscle and heart (Ringseis et al., 
2012).  
As previously mentioned, Wall and colleagues (2011) completed a study that examined 
the effects of oral L-carnitine and carbohydrate ingestion on muscle carnitine concentrations and 
fuel metabolism during endurance exercise. Researchers were able to demonstrate that muscle 
carnitine concentrations could be increased (~15%) in the presence of high serum insulin levels 
as well as hypercarnitinaemia (550-600 μmol). On three different occasions over a 24-week 
period, participants underwent a 90-minute cycling protocol at various intensities (50% and 80% 
of VO2max) to determine whether or not carnitine supplementation, in combination with 
carbohydrates, had any effect on body composition, carnitine concentrations in the muscle, or 
fuel metabolism. The results of the study revealed no body mass changes in the carnitine group 
over the 24-week period. However, when compared to the control group, plasma total carnitine 
(TC) concentrations increased in the carnitine group from 12 to 24 weeks, and perceived exertion 
was also significantly lower in the carnitine group (p < 0.05) compared to baseline and control (p 
< 0.05) after 24 weeks. 
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Short-term vs. Chronic Carnitine Supplementation 
Currently, few studies can propose a standard period of time that would indicate an ideal 
protocol for carnitine supplementation and thus far, the daily requirement of exogenous carnitine 
supplementation is unknown (Broad, Bolger, & Galloway, 2006). For example, Orer and 
colleagues (2014) examined the effect of two different doses of acute carnitine supplementation 
on endurance performance in athletes. Twenty-six healthy trained males (ages 17-19 years) were 
recruited for the study. Using a double-blind protocol, each participant was instructed to 
consume either 3g (LK-3) or 4g (LK-4) of L-carnitine mixed with fruit juice 1 hour before 
measurements were taken. The subjects then completed a progressive treadmill test to 
exhaustion, where heart rate was observed during the test, and blood samples were taken 
afterwards to measure blood lactate concentrations. One week after the completion of the test, 
the athletes returned to the testing site where they underwent the same procedure, however, this 
time they were given placebo fluids (P-3) and (P-4). When comparing both sets of groups (LK-3 
and P-3, and LK-4 and P-4) significant differences could be noted. A significant difference was 
found regarding heart rate and lactate (La) concentrations between the LK-4 and P-4 groups (p ≤ 
0.05) whereas heart rate and La dropped between running speeds of 8 and 16 km/h. Furthermore, 
significant decreases could be noted in the running speeds in both supplemented groups 
compared with placebos (p ≤ 0.05).  
In addition, Arazi and Mehrtash (2017) examined the effect of acute carnitine feeding on 
plasma glucose and lactate concentration, as well as aerobic and anaerobic capacity in elite male 
artistic gymnasts. Eighteen gymnasts were recruited for the study and, using a double-blind, 
placebo-controlled randomized protocol, subjects were divided into two groups: supplementation 
or placebo. Subjects were instructed to perform both an aerobic (20 m shuttle run) and anaerobic 
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running-based sprint (RAST) test. 90 minutes prior to the test, subjects in the supplementation 
group consumed 3 g of L-carnitine or placebo (maltodextrin) with 200 ml of water. Researchers 
collected blood samples 5 minutes before and 4 minutes after the performance trials to assess 
lactate and glucose. Results of this study found that, compared to the placebo group, lactate 
concentrations in the supplementation group were significantly lower (p  0.05) after the aerobic 
(140.4 ± 15.5 mg/dl) and anaerobic (147.8 ±12.8 mg/ dl) exercise tests.   
Another example of acute carnitine feeding was in a study done by Parandak and 
colleagues (2015) where the effects of acute carnitine ingestion on exercise-induced oxidative 
stress and muscle damage were examined. Participants for the study consisted of twenty-one 
healthy, active men. Preliminary testing included a VO2max test using the Balke 15-min run test 
on a standardized track where participants were encouraged to give maximum effort. In a 
randomized, double blind, placebo-controlled manner, participants were assigned to one of two 
groups - carnitine (C) or placebo (P) - based on their VO2max. For fourteen days, participants 
consumed a daily dose of either 2 capsules containing 2,000 mg L-carnitine or the placebo (2 
capsules containing 2,000 mg lactose). Following the 14-day period, the same VO2max test was 
administered to the participants under the same conditions. Results of the study revealed no 
changes in body composition over the two-week period, however, there were significant 
increases in markers of muscle damage (i.e., lactate dehydrogenase activity (p < 0.05), creatine 
kinase activity (p > 0.05), and total antioxidant activity (p < 0.05)) immediately after, as well as 
2 and 24 hours post exercise in both groups. In addition, there was no significant difference 
between running records for the two groups (P group: 73±8.2 vs C group: 71±6.8 min), however, 
this may be due to the subjects being placed in groups possessing similar VO2max values. Overall, 
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this study was able to demonstrate that acute L-carnitine supplementation may help to alleviate 
some of the side effects of short bouts of exercise, but more research is needed.  
Likewise, a study by Abramowicz and Galloway (2005) compared the effects of acute vs. 
chronic L-carnitine L-tartrate (LCLT) supplementation on metabolic responses to steady state 
exercise in males and females. Twelve active, healthy subjects volunteered for the study: six 
males (age 25 ± 6 years) and six females (age 30 ± 5 years). Subjects were randomly divided, in 
a double-blind crossover design, into 3 periods: placebo (14 days of 3 g glucose/day), acute 
supplementation (13 days of 3 g glucose/day, plus 1 day of 3 g LCLT), or chronic 
supplementation (14 days of 3 g/day LCLT). Over a period of seven weeks, subjects reported to 
the lab on a total of six occasions where they underwent various testing. The first visit consisted 
of a VO2max test using an incremental cycle ergometer; the second and third visits were used as 
familiarization trials and to determine correct workload. During the final three trials, subjects 
were asked to cycle for 60 minutes at 60% of their VO2max. Blood samples were collected 
throughout the exercise protocol to determine blood lactate and plasma glycerol concentrations, 
and perceived exertion (6-20 Borg scale), respiratory exchange ratio (RER), and heart rate were 
monitored as well. The results of the study show that, over the course of the 60-minute exercise, 
RER decreased significantly in both genders (p < 0.01). In male subjects, a higher RER was 
observed in the chronic ingestion trial compared to placebo (p = 0.04), with no difference 
between placebo and acute trials (p = 0.78). On the other hand, no significant differences were 
seen between groups in the female population in either the acute (p = 0.07) or chronic (p = 0.06) 
ingestion trials. Overall, the increased RER in the male population indicated an increased 
reliance on CHO metabolism, with a decreased reliance on fat metabolism, throughout the 60-
minute exercise protocol for both genders. The current study does not support the effect of a 
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single dose (2-weeks) of L-carnitine L-Tartrate, in combination with CHO ingestion, on 
promoting fat oxidation during exercise, however, there is an enhanced rate of CHO oxidation.  
 As previously mentioned, recent research has reported that chronic ingestion of L-
carnitine and CHO has been shown to prolong exercise endurance as well as aid in the recovery 
of muscles post-exercise. For example, Wall et al. (2011) conducted a study on moderately 
trained male athletes (age 25.9 ± 2.1 years) to demonstrate that muscle carnitine concentrations 
could be increased in association with elevated serum insulin levels ( >50 mU 1-1) and 
hypercarnitinemia (550–600 μmol-1). The results of the study showed that muscle carnitine 
content was increased by 21% via dietary carnitine supplementation.  Additionally, the 
researchers could demonstrate that carnitine had an ergogenic effect on the subjects, shown by an 
increased work output of 11% from basal measurements. Findings such as these reveal that 
carnitine feeding may have certain implications for athletic performance and suggest that muscle 
carnitine concentrations can be increased in individuals without deficiencies (Sahlin, 2011).  
Research is currently lacking on whether carnitine supplementation can enhance fat 
oxidation in healthy humans; however, some researchers believe that carnitine may have 
additional benefits in terms of exercise recovery. To date, few studies have been able to 
determine a specific dose response for LC supplementation. For example, Spiering and 
colleagues (2007) examined the responses of criterion variables to different supplemental doses 
of L-carnitine L-Tartrate (LCLT). The study recruited eight healthy male weightlifters (ages 22 ± 
3 years) with a year or more of squatting experience. Subjects consumed either 0 g, 1 g, or 2 g of 
LCLT at breakfast and lunch for 3 weeks followed by a subsequent squat exercise test. Handgrip 
was used to determine maximal strength of the arm musculature as well as blood draws to 
determine the appropriate washout period for carnitine concentrations to return to normal. 
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Perceived muscle soreness was also assessed at 24, 48, and 72 hours post resistance exercise 
(RE) test. Results showed that carnitine concentrations increased with the carnitine doses of 1 g 
and 2 g but a significant decrease in muscle soreness was noted in the 2 g dose compared to 1 g 
and the 1 g dose compared to 0 g. In conclusion, LCLT supplementation favorably affects 
markers of muscle damage and recovery after a bout of resistance exercise and even doses as 
little as 1 g per day can supply many of the same benefits associated with 2 g per day of LCLT.  
L-carnitine and Fatigue 
Although more research is necessary, some studies suggest that carnitine supplementation 
may attenuate the effects of fatigue by providing a protective effect on the blood platelets in the 
body that play a role in wound healing (Orer & Guzel, 2014). Carnitine is thought to play an 
important role in shortening the recovery process and attenuating the damage to the muscles 
caused during strenuous exercise (Orer & Guzel, 2014). For example, Cruciani and colleagues 
(2015) examined the effects of carnitine supplements on patients with HIV/AIDS in a 
randomized, double blind, placebo-controlled study. Thirty-five adults with advanced HIV/AIDS 
and moderate to severe fatigue were recruited for this study. Participants were randomly assigned 
to one of two groups - 3 g oral carnitine (increasing from 0.5 mg daily to 1.5 g twice daily by day 
7) or placebo for 2 weeks. The primary outcomes that were measured included the physical, 
emotional, social and functional wellbeing of the patients, performance status, mood, serum 
carnitine level, serum lactate level, CD4 count, and more importantly, Brief Fatigue Inventory. 
Results of the study concluded that carnitine supplementation did not reduce fatigue in any of the 
35 subjects. Likewise, carnitine supplementation did not have any effect on behavioral outcomes. 
On the other hand, plasma lactate concentrations fell in the carnitine group compared to the 
placebo group and plasma total and free carnitine levels increased. This study was unable to 
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support the use of carnitine supplementation to reduce feelings of fatigue in advanced HIV/AIDS 
patients with moderate to severe fatigue. Although the results of this study were inconclusive, 
future studies may benefit from increasing the dose/duration of the carnitine supplementation in 
hopes to produce significant findings.  
One study done by Yu and colleagues (2011) examined the effects of a single dose of L-
carnitine on the antioxidant capacity in healthy men and women (mean age 27.7 ± 4.7 years). 
Subjects consumed 2.0 g L-carnitine in 200 mL warm water, where venous blood samples were 
then taken at various time points between 0 and 24 hours after administration to determine 
plasma carnitine concentrations. For this study, researchers measured plasma antioxidant status 
in all subjects via the enzymes superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), 
and catalase and total antioxidative capacity (T-AOC) activity. A gradual increase in SOD 
concentration, as well as GSH-Px, and catalase T-AOC from 0 h to 3.5 h, whereas levels peaked 
at 3.5 h, and gradually returned to 0 h at the 24 h point. Overall, the increase in activity of these 
antioxidant enzymes suggests that a single dose of L-carnitine in healthy human subjects may be 
useful in treating certain cardiovascular and other chronic diseases that are associated with high 
levels of oxidative stress.  
Female Menstrual Cycle and Performance 
As females become more involved in amateur and professional sports, being familiar 
with how the menstruation cycle may affect performance becomes especially important. 
Researchers became more interested in examining the effects of the female menstrual cycle on 
athletic performance (Tsampoukos, Peckham, James, & Nevill, 2010) and whether or not the 
menstrual cycle phase could possibly hinder athletic ability. For instance, Tsampoukos and 
colleagues (2010) examined the effects of the menstrual cycle phase (MCP) on sprinting and the 
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recovery response to exercise. Fourteen highly trained female sport science students (mean age 
20.1 ± 0.3 years) volunteered for the study. Subjects were eumenorrheic, were studied prior to 
ovulation, and refrained from taking any oral contraceptives for at least 4 months prior to the 
study. Two important hormones associated with the menstrual cycle – 17 B-estradiol and 
progesterone, were noted for this study. Once preliminary trials were done, subjects completed a 
performance test on three different occasions (follicular phase, just prior to ovulation, luteal 
phase) consisting of a 30-sec sprint with a 2-min recovery period on a non-motorized treadmill. 
Peak power output (PPO), mean power output (MPO), fatigue index for power (FIPO), peak 
speed (PS), mean speed (MS) and fatigue index for speed (FISP) were measured during the 
performance test and blood samples were analyzed at different time points during and after the 
test (rest, post-warm-up, immediately after the first sprint, immediately after the second sprint 
and at 5, 10, 15, 20 and 30 min during the recovery from the second sprint). Results of the trials 
determined that, for the 8 subjects included in the study, no significant changes in body mass 
could be seen (p > 0.05). Furthermore, no significant changes in any of the performance 
variables were seen, as they were unaffected by MCP (p >0.05). The main findings of this study 
conclude that athletic performances on a 30-second sprint test were not influenced by the 
hormonal fluctuations of MCP or by 17 B-estradiol and progesterone, which fluctuate during the 
menstrual cycle. This research supports the notion that MCP likely does not affect performance 
in the female athlete under eumenorrheic conditions. 
Another point to consider when females are readily involved in endurance training is the 
use of oral contraceptives. Plasma ethanol estradiol, a hormone found in many oral 
contraceptives, inhibits the production of the hormone 17 B-estradiol, and appears six times 
higher in individuals taking oral contraceptives than those that do not (Joyce, Sabapathy, Bulmer, 
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& Minahan, 2013). A study by Joyce and colleagues (2013) set out to determine the effect of 
long-term use of oral contraceptives on the endurance performance of 16 recreationally active 
women. The participants were separated into two groups: oral contraceptive (OC) and those who 
were not using oral contraceptives (CON). Once separated, baseline blood samples were taken to 
assess 17 B-estradiol and progesterone levels. Then, participants completed an incremental 
exercise test to exhaustion on an electronically braked cycle ergometer to determine peak VO2 
(VO2peak) and anaerobic threshold (AT). The test consisted of 3 minutes of cycling at 30 W, 
followed by power increments at 10 W for 30 seconds until volitional exhaustion. Participants 
also completed four submaximal exercise tests (the first two as practice tests) that involved 
cycling at a cadence of 70 RPM for three work stages. During the tests, heart rate (HR), ratings 
of perceived exertion (RPE), pulmonary gas exchange, blood lactate concentration (La), and time 
to exhaustion were measured. Overall, significant differences were observed in VO2peak (P = 
0.03) and VO2 at AT (P = 0.02) in the CON group when compared to the OC group. However, 
HR, BP, and La concentrations were not significantly different between the groups. The results 
of the current study propose that long-term use of oral contraceptives negatively effect VO2peak 
and VO2 at AT, but have no effect on athletic performance in recreationally trained female 
endurance runners.   
The menstrual cycle can be divided into four phases: the menstrual phase, the follicular 
phase, the ovulation phase, and the luteal phase. For the most part, studies suggest that the 
menstrual cycle does not affect athletic performance in females; however, a study by Ubukata 
and Matsumura (2015) suggests that the menstrual cycle can be affected during these different 
phases. Ubukata and Matsumura (2015) suggest that injuries occur more often in females during 
the menstrual phase than the rest of the menstrual cycle, since estrogen and progesterone levels 
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are low during this time. For this study, researchers examined the relationship between the 
phases of the menstrual cycle and the transverse abdominis muscle (TrA). Fifteen healthy, young 
females (age 18.6 ± 0.9 years) with regular menstrual cycles were chosen for this study. The 
thickness of the TrA was measured a total of three times, using an ultrasound imaging apparatus 
under both resting and contractile conditions. Likewise, both the left and the right side were 
measured and the average thickness of the muscle on both sides used for analysis.  The results of 
the study showed that, regardless of menstrual cycle phase, the thickness of the TrA muscle 
increased significantly during contraction.  Overall, researchers were unable to observe any 
significant differences in muscle thickness of the TrA in the menstrual cycle phase; thus, muscle 
contraction was not affected during the fluctuation of sex hormones, indicating the TrA does not 
depend on the menstrual cycle.  
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CHAPTER 3 
METHODOLOGY 
Participants 
Eight, healthy, recreational female endurance runners were recruited for this study. 
Volunteers were college students between the ages of 19 and 22 years old. The Institutional 
Review Board (IRB) at Georgia Southern University approved this study. The participants were 
informed of the possible risks involved with participating in this study and completed written 
informed consent. The participant’s demographic information was collected, which included the 
number of days per week they were currently running and how long each running session 
typically lasted. All participants were also asked to complete a 72-hour dietary recall to assess 
average carbohydrate intake, as well as average carnitine intake.  
 
Instrumentation 
Participants had their weight and height assessed in the human performance lab at 
Georgia Southern University using a calibrated scale and stadiometer during the first week of the 
study. Participants also completed a 72-hour dietary recall during the first week before the first 
trial to assess average carbohydrate and carnitine intake. Participants were asked to maintain 
their current training regimen and diet throughout the duration of the study. During the first trial, 
participants completed a body composition assessment using the Bod Pod® and performed a 
timed treadmill test to exhaustion. For the BodPod body composition analysis, optimal results 
require participants to wear minimal clothing (spandex shorts and/or a sports bra) and a swim 
cap. They are then weighed on a calibrated digital scale to the nearest 20 g. Next, the participant 
sat in the air displacement plethmysography (ADP) chamber and be asked to breathe normally 
while three body measurements will be taken to assess body volume. In addition, thoracic gas 
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volume measurements were predicted using gender, age, and height. Measurements taken from 
the BodPod include: lung volume (L), body volume (L), body density (kg/L), body fat 
percentage, fat weight (kg), and lean weight (kg).  
During the first visit, each participant was given oral and written information regarding 
the testing procedures. Participants performed a VO2peak test one week before the first trial, and 
were asked to complete a second VO2peak test one week after the final trial to verify that no 
changes in aerobic capacity had occurred over the course of the study.  Expired gases were 
analyzed using the ParvoMedics TrueOne® 2400 open circuit spirometry system. This consists 
of a room air auto-calibration routine and a two-point gas calibration with a single gas tank 
(15.09% O2, 6.01% CO2). The ParvoMedics TrueOne® 2400 has been shown to be an accurate 
and reliable device for the measurement of gas exchange variables (Crouter et al., 2006). All 
measurements were taken in the human performance lab at Georgia Southern University in the 
same session.  
Procedures 
Food Log Protocol: Prior to the first trial, participants were instructed to complete a 72-
hour measured dietary recall (one weekend day and two week days). Participants downloaded the 
MyFitness Pal app that is available on both iPhone and Android devices. The dietary recall was 
analyzed for an estimate of baseline carbohydrate intake, as well as total daily macronutrient 
intake. An estimate of carnitine consumption was also determined using a calculation used in 
previous research (Rebouche, 1999).   
Exercise Protocol: One week before the trial, each participant’s maximal oxygen uptake 
(VO2peak) was measured while participants ran on a treadmill to determine baseline 
measurements. Upon arrival, height (cm) - measured using a stadiometer, weight (kg) - measured 
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using a calibrated scale, and body mass index (kg/m2) was determined. Participants were 
instructed to 1) wear comfortable, loose-fitting clothing, 2) refrain from consuming any alcohol, 
tobacco, or caffeine for at least 12 hours prior to taking the test, 3) refrain from participating in 
any strenuous physical activity the day before, as well as the day of the test, 4) get an adequate 
amount of sleep the night before the test (6-8 hours).  
Prior to testing, participants were fitted with headgear, a mouthpiece and a nose clip. 
Heart rate was monitored continuously throughout the protocol by a Polar® Heart Rate monitor 
with a sensor located on the chest. Participants completed a 3-5 minute warm-up at a self-
selected speed at a 0° grade. The participant was informed that this self-selected speed should be 
similar to a light jog, nothing too taxing on the runner. The speed the participant chose to run at 
determined the starting point for their exercise protocol.  After the initial warm-up, the test began 
and was comprised of 2-minute stages. In each stage, speed was raised by 1.0 mph and after the 
third stage, grade increased by 2% per stage.  Through the duration of the test, various criteria 
was monitored including: VO2, heart rate (HR), respiratory exchange ratio (RER), and rate of 
perceived exertion (RPE). RPE (Borg Scale 6-20) was taken at the end of each stage. Criteria for 
ending the test included: (1) a plateau in oxygen uptake (2) maximal heart rate was reached (3) 
RER > 1.15 (4) volitional exhaustion (the point at which the participant voluntarily stopped the 
exercise). The test was discontinued if all test criteria were achieved or when the participant 
chose to stop.  
One week after the pre-testing, subjects returned for the first trial, performing a 
progressive treadmill test (0° gradient) to exhaustion. Participants began by running at 8 km/h 
and the running speed increased every three minutes by 2 km/h until 16 km/h was reached or 
exhaustion was achieved. Thereafter, the speed increased every two minutes by 1 km/h until 
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exhaustion, at which point the test was then terminated. Peak running speed was measured at the 
highest running speed (km/h) the athlete could maintain for 60 seconds during the exercise test. 
During the duration of the test, heart rate and perceived exertion were monitored and time to 
fatigue was also noted.  
Supplementation Protocol: Participants were divided into two groups based on similar 
VO2peak values and then randomly assigned to one of two treatment groups: LC or LC+CHO. 
Subjects were then instructed to consume their treatment two times per day for 42 days - the first 
supplement 30 minutes before breakfast, and the second supplement 4 hours later or 20-30 
minutes before exercise, per the manufacturer’s directions on the bottle. Volunteers were 
requested to record any side effects associated with supplementation over the 8-week protocol. 
The composition of the supplements is outlined below.  
L-Carnitine  (LC) Group: 1 scoop (1.30 g) carnitine powder (Gaspari Nutrition ® 
Carnitine Tartrate [as Carnipure™] in the flavor Pineapple) mixed with 200 mL of water 
containing 0 g CHO, 0 g protein, 0 g fat; Zero Calories per serving. 
L-Carnitine + Carbohydrate (LC + CHO) Group: 1 scoop (1.30g) carnitine powder 
(Gaspari Nutrition ® Carnitine Tartrate [as Carnipure™] in the flavor Pineapple) and 10 
g NOW! Dextrose Powder mixed with 200 mL water. The supplement will contain 9 g 
CHO, 0 g protein, 0 g fat; 35 calories per serving. 
Supplements were assembled by the researcher in advance and given to participants on 
the day of the first exercise session, and again when they returned for the second exercise 
session. Directions for supplement use were given verbally and were also written on the 
container that held the supplements.  
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Study Time Line 
 Week 1: An informational meeting was held with the participants, during which, the 
experimental procedures of the three sessions were reviewed. The timeline for the experiment 
was explained to the participants during this time. Each participant read and sign the informed 
consent. The researcher clearly explained to the participants that study participation was 
voluntary. During week 1, the researcher took anthropometric (height and weight) measurements 
of the participants. The participants were also provided with instructions on how to record the 
measured food intake for the dietary recall. Also during week one, participants completed a 
VO2peak test to assess maximal oxygen uptake. Subjects were then divided into two groups based 
on VO2peak values, and then randomly divided into one of the two treatment groups. 
Group 1: L-carnitine 
Group 2: L-carnitine + carbohydrate 
 Week 2-4: Measured food logs were shared with the researcher on the first day of testing 
to assess total carbohydrate and carnitine intake. Participants completed a progressive treadmill 
test to exhaustion as well as a body composition assessment (Bod Pod). Participants began the 
supplementation regimen the day after the first exercise session.  
 Week 5-6: Participants completed the second session of treadmill testing and body 
composition assessments and continue their daily supplementation regimen.  
 Week 7: Subjects completed the third, and final, session of treadmill testing and body 
composition assessments and supplementation ended. 
 Week 8: Subjects returned for final VO2peak testing. 
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Statistical Analysis 
Three one-way ANOVAs with repeated measures were conducted to compare the effect 
of the treatment (LC or LC + CHO) on the participants’ average time to fatigue, average 
body composition, and average RPE. It was assumed that participants would return for all 
required exercise protocols; would take their required dosages of the supplement given; 
would take their required supplements at the correct time and frequency throughout the day; 
participants would not be taking any performance enhancing drugs at the time of the study; 
would continue with their current diet and training regimen throughout the duration of the 
study; the Bod Pod® is a reliable and valid measure of body composition; and the 
ParvoMedics TrueOne® 2400 proves to be an accurate and reliable device for the 
measurement of gas exchange variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
38 
CHAPTER 4 
RESULTS 
 
For average time to fatigue, the analysis revealed no significant interactions or main 
effects for time and treatment, Wilks’ Lambda = .33, F (2,4) = 4.02, p = .11, 2partial = .668. In 
addition, no significant differences were seen between or within subjects for body composition 
(%FFM, Wilks’ Lambda = .74, F(2,4) = .72, p = .54, 2partial = .26; FFM, Wilks’ Lambda = .41, 
F(2,4) = 2.89, p = .17, 2partial = .59; FM, Wilks’ Lambda = .87, F(2,4) = .31, p = .75, 2partial = 
.13 or %FM, Wilks’ Lambda = .76, F(2,4) = .64, p = .57, 2partial = .24) or RPE, Wilks’ Lambda 
= .97, F(2,4) = .06, p = .95, 2partial = .03.  
Participant Characteristics 
Seven female participants completed the study. One subject was removed from the study 
after failure to adhere to required criteria for the study. All other participants reported to the 
study for all testing sessions. Descriptive statistics are summarized in Table 1. 
Participants performed a VO2peak test before experimental testing began. Participants were 
then divided into groups based on similar VO2peak values, as this indicates similar levels of 
fitness. Participants in both groups were tested before and after the 8-week supplementation and 
exercise protocol to assess pre- and post-test values. Table 2 shows the results of the pre- and 
post- VO2peak test for both supplement groups.  
Participants’ time to fatigue was recorded after each progressive treadmill test. An 
ANOVA with repeated measures was used to compare time to fatigue between and within both 
supplement groups before and after the 8-week supplementation period. Results of the analysis 
revealed no significant interactions or main effects for time and treatment (p = .11), however, 
analysis revealed a large effect size (2partial = .668).  
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In addition to the progressive treadmill test, participants were required to have body 
composition measurements performed using the BodPod body analyzer. Body composition 
measurements were performed before each progressive treadmill test and included percent fat 
free mass (%FFM), fat free mass (FFM), fat mass (FM), and percent fat mass (%FM). An 
ANOVA with repeated measures was used to compare body composition between and within 
both supplement groups before and after the 8-week supplementation period. The ANOVA 
revealed no significant differences between subjects for body composition (%FFM p = .54; FFM 
p = .17; FM p = .75; or %FM p = .57) but did show a large effect size for all components of the 
body composition assessment (2partial = .26, 2partial = .59, 2partial = .13, 2partial = .24, 
respectively). Tables 4, 5, 6, and 7 display the data collected from each assessment.  
Furthermore, rating of perceived exertion was recorded during each progressive treadmill 
test. An ANOVA with repeated measures was used to compare ratings of perceived exertion 
between and within both supplement groups before and after the 8-week supplementation 
protocol. Table 8 shows the results of the rating of perceived exertion for both supplement 
groups for each exercise protocol.  Results of the analysis revealed no significant differences 
between or within subjects for both groups (p = .95).  
In order to get an idea of the average number of carbohydrates and carnitine consumed by 
each participant, average carbohydrate and carnitine intake were assessed using a 72-hour dietary 
recall. Details of the recall are outlined in Table 9 and 10.  
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Table 1 
Summary of information of subject age, weight, and other contributing factors (n = 7) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 
Average VO2max values for both treatment groups before and after supplementation(n=7) 
 
 
Table 3  
Average Time to Fatigue for Trial 1, 2, and 3 for both supplement groups(n=7) 
 Treatment Mean Std. Deviation N 
Time to Fatigue 
Session 1 (min) 
 
LC 
LC+CHO 
Total 
7:49 
11:31 
9:24 
2:02 
0:51 
2:29 
4 
3 
7 
Time to Fatigue 
Session 2 (min) 
 
LC 
LC+CHO 
Total 
7:54 
10:42 
9:06 
1:18 
0:48 
1:48 
4 
3 
7 
Time to Fatigue 
Session 3 (min) 
 
LC 
LC+CHO 
Total 
8:19 
11:31 
9:27 
1:20 
0:45 
1:55 
4 
3 
7 
 
 
 
 
 
 
 
 
 
Variable Mean  SD 
Age (years) 20.28  1.25 
Weight (kg) 140.85  19.33 
Height (cm) 171.42  7.63 
Days run/week 4.78  0.80 
Time run/day (min) 37.92  13.72 
Average calories/day (kcal) 1675.85  474.61 
Average carnitine intake/day (mg) 13.42  10.69 
Average carbohydrate intake/day (g) 181.44  56.94 
Variable Mean  SD 
LC (Pre) 38.26  1.05 
LC+CHO (Pre) 45.83  2.20 
LC (Post) 41.80  1.76 
LC+CHO (Post) 45.50  0.85 
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Table 4 
Average Percent Fat Free Mass for Trial 1, 2, and 3 for both supplement groups (n=7) 
 Treatment Mean Std. Deviation N 
Percent Fat Free 
Mass Session 1 
 
LC 
LC+CHO 
Total 
74.83 
80.40 
77.21 
5.95 
6.19 
6.27 
4 
3 
7 
Percent Fat Free 
Mass Session 2 
 
LC 
LC+CHO 
Total 
75.38 
81.47 
77.99 
6.78 
6.55 
6.92 
4 
3 
7 
Percent Fat Free 
Mass Session 3 
 
LC 
LC+CHO 
Total 
75.38 
81.17 
77.43 
5.26 
7.26 
6.16 
4 
3 
7 
 
 
Table 5 
Average Fat Free Mass for Trial 1, 2, and 3 for both supplement group (n=7) 
 Treatment Mean Std. Deviation N 
Fat Free Mass 
Session 1 (kg) 
 
LC 
LC+CHO 
Total 
55.90 
54.90 
55.47 
26.06 
4.65 
18.63 
4 
3 
7 
Fat Free Mass 
Session 2 (kg) 
 
LC 
LC+CHO 
Total 
57.33 
55.57 
56.57 
23.60 
3.57 
16.84 
4 
3 
7 
Fat Free Mass 
Session 3 (kg) 
 
LC 
LC+CHO 
Total 
44.98 
54.83 
49.20 
4.12 
3.65 
6.38 
4 
3 
7 
 
 
Table 6 
Average Fat Mass for Trial 1, 2, and 3 for both supplement groups (n=7) 
 Treatment Mean Std. Deviation N 
Fat Mass Session 1 
(kg) 
 
LC 
LC+CHO 
Total 
14.98 
13.83 
14.49 
4.75 
6.48 
5.07 
4 
3 
7 
Fat Mass Session 2 
(kg) 
 
LC 
LC+CHO 
Total 
18.40 
13.13 
16.14 
7.12 
6.81 
6.98 
4 
3 
7 
Fat Mass Session 3 
(kg) 
 
LC 
LC+CHO 
Total 
14.80 
14.10 
14.50 
4.27 
7.41 
5.25 
4 
3 
7 
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Table 7 
Average Percent Fat Mass for Trial 1, 2, and 3 for both supplement groups (n=7) 
 Treatment Mean Std. Deviation N 
Percent Fat Mass 
Session 1 (%) 
 
LC 
LC+CHO 
Total 
25.18 
19.60 
22.79 
5.95 
6.19 
6.27 
4 
3 
7 
Percent Fat Mass 
Session 2 (%) 
 
LC 
LC+CHO 
Total 
24.63 
18.60 
22.04 
6.78 
6.67 
6.94 
4 
3 
7 
Percent Fat Mass 
Session 3 (%) 
 
LC 
LC+CHO 
Total 
24.63 
19.83 
22.57 
5.26 
7.26 
6.16 
4 
3 
7 
 
 
Table 8 
Average Rating of Perceived Exertion for Trial 1, 2, and 3 for both supplement groups (n=7) 
 Treatment Mean Std. Deviation N 
Rating of Perceived 
Exertion Session 1 
 
LC 
LC+CHO 
Total 
15.00 
18.00 
16.29 
1.63 
1.73 
2.22 
4 
3 
7 
Rating of Perceived 
Exertion Session 2 
 
LC 
LC+CHO 
Total 
16.25 
17.00 
16.57 
1.50 
.00 
1.13 
4 
3 
7 
Rating of Perceived 
Exertion Session 3 
 
LC 
LC+CHO 
Total 
16.50 
17.00 
16.71 
1.00 
.00 
0.76 
4 
3 
7 
 
 
Table 9 
Average carbohydrate intake (g) prior to the start of the study (n=7) 
 
 
Table 10.  
Average carnitine intake (mg) prior to the start of the study (n=7)  
Group Mean  SD 
LC 16.50  14.01 
LC+CHO 9.30  2.08 
 
 
Group Mean  SD 
LC 163.72  72.37 
LC+CHO 204.86  20.77 
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CHAPTER 5 
DISCUSSION 
One of the many functions of carnitine is its role in the translocation of long-chain fatty 
acids into the mitochondrial matrix for subsequent B-oxidation (Stephens, Constantin-Teodosiu, 
& Greenhaff, 2007). Over the last decade, researchers have been investigating the effect of 
carnitine supplementation as an ergogenic aid, with the idea that increasing carnitine availability 
in the muscle would increase fat oxidation and spare muscle glycogen stores, thus delaying the 
onset of fatigue. However, limited research has been able to support the use of carnitine 
supplementation to enhance athletic performance, and previous research has shown that carnitine 
feeding has no effect on muscle carnitine stores in the body. As previously mentioned, there is 
limited research on carnitine supplementation, particularly with carnitine in combination with 
carbohydrates. The purpose of this study was to examine the effect of L-carnitine, in 
combination with carbohydrates, on body composition and overall athletic performance in 
recreational female endurance athletes.  The results of this study revealed no significant 
interactions or main effects for time and treatment for time to fatigue. In addition, no significant 
differences were seen between or within subjects for body composition.  
Previous research has shown that L-carnitine supplementation can affect performance and 
fatigue in endurance athletes (Karahan et al., 2010; Stephens et al., 2013; Arazi & Mehrtash, 
2017). To date, studies investigating the effect of LC supplementation on exercise performance 
have used gas-analysis techniques as well as cycle ergometry to evaluate performance variables, 
as exercise modality plays a role in ventilatory patterns. A study by Tanner, Duke, and Stager 
(2014) examined the effect of different modes of exercise on ventilatory patterns. Data collection 
showed that, although no observed differences were seen in ventilation (VE) between running 
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and cycling during the maximal exercise test, different breathing patterns were observed. This 
difference in breathing pattern is important to the current study to distinguish the physiological 
differences between treadmill running versus biking, as the current study utilized the treadmill in 
assessing exercise performance.  
Some studies have suggested that athletes are able to withstand higher workloads at lower 
levels of oxygen consumption during exercise after a single dose of L-carnitine (Vecchiet, Di 
Lisa, & Pieralisi, 1990). The function of carnitine during mitochondrial metabolism may be a 
contributing factor to the overall increase in effectiveness of oxygen utilization, as other studies 
have seen decreases in respiratory exchange ratio (RER) values during VO2max testing during L-
carnitine supplementation (Wyas, Ganzit, & Reizi, A, 1990). For example, Swart and colleagues 
(1997) examined the effect of L-carnitine supplementation on plasma carnitine levels and various 
performance parameters of male marathon athletes. After six weeks of L-carnitine 
supplementation, the results of the study revealed a 5.68% average increase in treadmill running 
speed compared to baseline values, and a decrease in average oxygen consumption and heart 
rate. In addition, a decrease in RER values were observed when compared to baseline values, 
which indicates an increased reliance on lipid oxidation as a fuel source during aerobic exercise.  
One of the aims of the current study was to assess average time to fatigue for each timed 
exercise trial and, unlike Swart and colleagues (1997), the current study did not find any 
significant differences in those measurements between or within participants. These results could 
be due to participants becoming accustomed to performing the exercise protocol or participants 
possessing similar levels of fitness in each group. Furthermore, the participants used in the study 
by Swart and colleagues (1997) were highly trained, triathlon athletes, whereas the participants 
used in the current study were recreational, college-aged endurance runners.  
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In addition, Orer and Guzel (2014) examined the effects of two different does of L-
carnitine on the endurance performance of male soccer players, aged 17-19 years. Based on 
blood samples obtained from participants, the researchers found differences in running speeds 
between groups at different lactate concentrations (2, 2.5, 3, 3.5, and 4 mmol/L-1), whereas 
fatigue occurred at a slower rate in both groups after carnitine supplementation compared with 
the placebo trial. The current study was unable to collect blood samples for analysis, thus 
preventing the examination of lactate concentrations in the blood. The findings from the study by 
Orer and Guzel (2014) showed that plasma lactate concentrations decreased after L-carnitine 
feeding, suggesting that carnitine may have the potential to help prevent muscle damage caused 
by exercise. Similarly, Arazi and Mehrtash (2017) also noticed significantly lower lactate levels 
in their supplementation group compared with placebo when examining acute L-carnitine 
supplementation on blood lactate, glucose, and anaerobic and aerobic performance in elite male 
artistic gymnasts. Workload is closely related to individual differences seen in lactate 
concentrations during exercise performance, therefore, future studies should determine which 
running speed at which heart rate an athlete reaches their anaerobic threshold.  
As mentioned previously, some studies have evaluated rating of perceived exertion (RPE) 
to gage perceived effort of participants (Orer & Guzel, 2014; Swart et al., 1997; Wall et al., 
2011) but have found conflicting results (Spiering et al., 2007; Wachter et al., 2002) when using 
this as a method of perceived work output. For example, Abramowicz & Galloway (2005) 
examined the effect of acute versus chronic L-carnitine supplementation on twelve moderately 
trained athletes. Results of the study found no significant differences between trials in rating of 
perceived exertion in either males or females. In contrast, Wall et al., 2011 found that after 24 
weeks, perceived exertion was lower in the supplement group compared to the control group.  
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Similar to the study by Abramowicz & Galloway (2005), the current study protocol 
utilized RPE to assess how hard participants believed they were working and participants in the 
current study were adapted to endurance-type training, which may have affected how hard they 
perceived they were working. This could potentially be the reason as to why the current study 
revealed no significant differences in rating of perceived exertion between or within groups for 
RPE. 
Overall, observing lactate concentrations would have been an ideal way to measure how 
much participants adapted to the work they were performing. Experienced runners will exhibit 
lower blood lactate levels when compared with untrained runners, making it a good indicator of 
training intensity because it does not require the use of heart rate or expired gases (Goodwin, 
Harris, Hernandez & Gladden, 2007). Future studies would benefit from collecting blood 
samples to better assess lactate concentrations, and ultimately, levels of fatigue. 
In addition to reducing levels of and time to fatigue, a popular claim associated with 
carnitine is that it aids in fat loss and helps prevent weight gain. Similar to the current study, 
previous studies involving L-carnitine supplementation have concluded that L-carnitine has little 
effect on body composition (Wutzke & Lorenz (2004); Broad, Maughan, & Galloway (2011)). 
For instance, Kruszewski (2011) examined the effect of L-carnitine supplementation, in 
combination with body building training, on body composition in beginner body builders using 
bioelectrical impedance analysis (BIA). Results of the study concluded that no significant 
changes were seen in the fat and water content of the participants after five weeks of L-carnitine 
supplementation. Like their study, the current study found no significant differences in body 
composition between or within subjects in both groups after eight weeks of L-carnitine 
supplementation. Furthermore, unlike the study by Kruszewski (2011), the current study used 
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recreationally-trained female endurance runners who met the ACSM guidelines of participating 
in at least 150 minutes of physical activity three to five times per week. They were also 
accustomed to performing endurance exercise, and therefore their fitness levels were most likely 
higher than the participants used in the study by Kruszewski (2011).  
The current study used the Bod Pod body analyzer to assess body composition, whereas 
previous studies typically utilize BIA or skinfolds for body composition measurements (Broad, 
Maughan, & Galloway, 2008). This difference in instrumentation may explain the lack of 
significant changes seen in body composition in the current study. In addition, participants may 
have violated some of the assumptions of the study by not fasting for a minimum of two hours 
before their body composition measurement or performing strenuous exercise prior to testing, 
which may have affected the results. Likewise, some participants had to be tested in the Bod Pod 
multiple times to get an accurate reading, as the data was not always consistent. Both the current 
study and the study by Kruszewski (2011) demonstrated that the claims made by manufacturers 
about L-carnitine may not always be true, however, L-carnitine dosing is very individualized and 
may be dependent upon the fitness and experience level of the individual (Kruszewski, 2011) to 
elicit any effect.  
Although previous studies have not supported the use of carnitine as a fat loss 
supplement, some more recent studies have shown the potential of L-carnitine supplementation 
to prevent increases in fat accumulation (Stephens et al., 2013); Wall et al., 2011). For example, 
Stephens and colleagues (2013) examined the effect of twelve weeks of L-carnitine feeding on 
energy expenditure and body fat accumulation in recreationally active males. Unlike the current 
study, results of their study showed no change in body composition in the LC group before or 
after supplementation, whereas the body composition of the control group increased in every 
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participant after twelve weeks. In addition, when examining the effects of L-carnitine 
supplementation in combination with carbohydrates on muscle carnitine concentrations and fuel 
metabolism during endurance exercise, Wall and colleagues (2011) found no changes in body 
mass in the carnitine group over a period of 24 weeks. They also noticed a 2.4 kg increase in 
body mass after the 12-week period in the control group when compared to baseline. Compared 
to the current study, the Wall (2011) study protocol extended a period of 24 weeks, whereas the 
current study supplementation period was only 8 weeks. In addition, participants in their study 
were male athletes training at least 3-5 times per week, performing triathlon-type exercise 
(biking, running, swimming). Previous research with carnitine supplementation suggests that 
longer supplementation periods have shown to be more successful in finding significant changes 
when examining body composition (Wall and colleagues, 2011; Stephens and colleagues, 2013).  
The study by Wall and colleagues (2011) also incorporated roughly 600 additional 
calories (80 g CHO) into the diets of their participants, while the current study protocol only 
included an additional 70 calories (22 g of carbohydrates). Participants in their study were 
informed of the caloric intake and told to account for it in the diet, but the low number of calories 
coming from carbohydrates in the current study protocol was most likely too small to elicit any 
type of physiological response such as weight gain. Unlike the studies by Wall (2011) and 
Stephens (2013), the current study reported overall caloric intake using a 72-hour dietary recall 
which isn’t always accurate.  
Swart and colleagues (1997) accounted for overall caloric consumption (energy from 
calories, carbohydrates, lipids, and protein) throughout the entire duration of their study, whereas 
the current study only had participants report average carbohydrate and carnitine intake over a 
72-hour period. Determining percentage of calories coming from lipid sources would be an 
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important factor to consider in future studies since lipids must be available for carnitine 
supplementation to be of any value during endurance exercise. Furthermore, it must be possible 
for those lipids to be utilized, which is also achieved through lower-intensity exercise. As 
mentioned previously, dietary carnitine is predominately obtained through animal protein 
sources and the participant’s diets in the current study, as well as in the study by Swart (1997), 
were more carbohydrate heavy, possibly resulting in a lower level of free carnitine in the body 
and thus, a slight deficiency. 
 Future studies may benefit from having participants record daily food logs throughout 
the duration of the study to keep track of energy consumed from macronutrients, as this is an 
important factor of overall lipid utilization and would be a more accurate way of determining 
caloric intake.  In addition to reporting overall caloric intake, the current study protocol 
instructed participants to maintain their current diet and exercise regimen throughout the study 
protocol but societal and psychological factors may have prevented participants from doing so. 
For instance, Spring Break fell in the middle of the study protocol and many participants left for 
vacation during that time. This made it difficult for the researcher in the current study to make 
sure participants were still maintaining their normal routine and taking the supplements 
accordingly.  
In conclusion, this study found that eight weeks of carnitine supplementation, in 
combination with carbohydrates, did not increase work output or decrease feelings of fatigue in 
female recreational endurance runners. In addition, eight weeks of carnitine and carbohydrate 
supplementation did not have a significant effect on body composition or rating of perceived 
exertion. This study attempted to simulate routine diet and exercise conditions for this specific 
population (college-aged recreational runners) during the supplementation protocol. Participants 
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in this study were college-aged recreational runners, therefore psychological and societal factors 
enhanced the possibility of diverging from normal diet and exercise routine, limiting their intake 
of the supplement and unknowingly altering body composition.  
Furthermore, the current study had a small sample size (n=7), which could have been 
attributed to the limited inclusion criteria initially set forth by the researcher. The small sample 
size prevented the use of a control group in addition to the two supplement groups. Having a 
control group and an experimental group allows the researcher to manipulate one aspect of the 
study and allows the researcher to see if the group getting the treatment behaves any differently 
from the group not receiving the treatment (Tetyana, 2012). Having a control group is important 
if the researcher wants to assess the impact of a certain treatment, thus future studies may benefit 
from having this group. Like mentioned previously, future studies would also benefit from 
obtaining blood samples from participants to analyze carnitine concentrations in the muscle as 
well as blood lactate concentrations after ingestion of the L-carnitine and carbohydrate 
supplement and exercise performance.  
Currently, many studies have been unable to support the use of carnitine supplementation 
to enhance athletic performance; however, these conclusions have been drawn based on small 
sample sizes, short duration of supplementation, type of supplementation, and lack of control of 
diet before and after supplementation (Abramowicz & Galloway, 2005). Despite the limitations 
in this study, the results suggest that consumers should be wary of the claims made by 
supplement companies that state L-carnitine helps prevent weight gain and promotes fat loss, as 
the data in this study suggest otherwise.  
 
 
  
51 
REFERENCES 
 
Abramowicz, W. & Galloway, D. (2005). Effects of acute vs. chronic L-carnitine L-tartrate     
supplementation on metabolic responses to steady state exercise in males and females. 
Journal of Sport Nutrition and Exercise Metabolism, 15, 386-400. 
 
ACSM Position Stand on The Recommended Quantity and Quality of Exercise for Developing  
and Maintaining Cardiorespiratory and Muscular Fitness, and Flexibility in Adults. 1998. 
Medicine and Science in Sports Exercise, 30(6), 975‐ 991.  
 
Arazi, H. & Mehrtash, M. (2017). Effect of acute l-carnitine supplementation on blood lactate, 
glucose, aerobic and anaerobic performance in elite male artistic gymnasts. Baltic Journal 
of Sport and Health Sciences, 1(104), 2-7.  
 
Broad, E., Maughan, R. & Galloway, S. (2005). Effects of four weeks L-carnitine L-tartrate 
ingestion on substrate utilization during prolonged exercise. Journal of Sport Nutrition 
and Exercise Metabolism, 15, 665-679. 
 
Broad, E., Bolger, C. & Galloway, S. (2006). Dietary carnitine intake and carnitine status in 
endurance trained males. Nutrition and Dietetics, 63(3), 148-154. 
 
Broad, E., Maughan, R. & Galloway, S. (2008). Carbohydrate, protein, and fat metabolism 
during exercise after oral carnitine supplementation in humans. International Journal of 
Sport Nutrition an Exercise Metabolism, 18, 567-584.  
 
Broad, E., Maughan, R. & GallowayS. (2011). Effects of exercise intensity and altered substrate 
availability on cardiovascular and metabolic responses to exercise after oral carnitine 
supplementation in athletes. Journal of Sport Nutrition and Exercise Metabolism, 21, 385 
-397.  
 
BOD®POD Body Composition Measurement Testing. 2013. Retrieved from 
http://www.nifs.org/fitness-center/fitness-assessments/bodpod 
 
Burke, L. 2007. Practical Sports Nutrition. 43-44.  
 
Carnitine shuttle. (2004, October 25). Retrieved May 27, 2016, from 
http://www.humpath.com/spip.php?article4428 
 
Crouter, S., Antczak, A., Hudak, J., DellaValle, D. & Haas, J. (2006). Accuracy and reliability of 
the ParvoMedics TrueOne 2400 and MedGraphics VO2000 metabolic systems. European 
Journal of Applied Physiology, 98(2), 139-151. 
 
Cruciani R., Revuelta M., Dvorkin E., Homel P., Lesage P. & Esteban-Cruciani, N. (2015). L-
Carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, 
placebo-controlled pilot study. Focus on Alternative and Complementary Therapies, 
20(2), 65–73. 
  
52 
 
Ehrlich, S. 2014. Carnitine (L-Carnitine). Retrieved from 
http://www.umm.edu/health/medical/altmed/supplement/carnitine-lcarnitine.  
 
Foster, D. 2006. The role of the carnitine system in human metabolism. Annals of the New York 
Academy of Sciences, 1033, 1–16.  
 
Goodwin, M.L., Harris, J.E., Hernandez, A., & Gladden, L.B. (2007). Blood lactate 
measurements and analysis during exercise: A guide for clinicians. Journal of Diabetes 
Science and Technology, 1(4), 558-569.  
 
Hottenrott, K., Ludyga, S. Schultze, S. (2012). Effects of high intensity training and continuous 
endurance training on aerobic capacity and body composition in recreationally active 
runners. Journal of Sports Science and Medicine, 11, 483-488.   
 
Howden, E.J., Perhonen, M., Peshock, R.M., Zhang, R., Arbab-Zadeh, A., Adams-Huet, B., & 
Levine, B.D. (2015). Females have blunted cardiovascular response to one year of 
intensive supervised endurance training. Journal of Applied Physiology, 119(1), 37-46.  
 
Jeukendrup, A. (2010). Carbohydrate and exercise performance: the role of multiple 
transportable carbohydrates. Current Opinion in Clinical Nutrition and Metabolic Care, 
13, 452–457.  
 
Joyce, S., Sabapathy, S., Bulmer, A. & Minahan, C. (2013). Effect of long-term oral 
contraceptive use on determinants of endurance performance. Journal of Strength and 
Conditioning Research/National Strength and Conditioning Association. 27(7), 1891-
1896. 
 
Maddalozzo, G., Cardinal, B. & Snow, C. (2002). Concurrent validity of the BOD POD and 
Dual Energy X-Ray Absorptiometry techniques for assessing body composition in young 
women. Journal of the American Dietetic Association, 102(11), 1677–1679. 
 
Karahan, M., Çoksevim, B. & Artis, S. (2010). The effect of l-carnitine supplementation on 
1500m running performance. Ovidius University Annals, Series Physical Education & 
Sport/Science, Movement & Health, 10(2), 504-507. 
 
Kraemer, W., Volek, J. & Dunn-Lewis, C. (2008). L-carnitine supplementation: Influence upon 
physiological function. Current Sports Medicine Reports, 7(4), 218-223. 
 
Kruszewski, M. (2011). Changes in maximal strength and body composition after different 
methods of developing muscle strength and supplementation with creatine, L-carnitine and 
HMB. Biology of Sport, 28, 145-150.  
 
Millet, G., Vleck, V. & Bentley, D. (2009). Physiological differences between cycling and 
running. Journal of Sports Medicine, 39(3), 179-206. 
 
  
53 
Office of Disease Prevention and Health Promotion. (n.d.). Adults. Retrieved from  
https://health.gov/paguidelines/guidelines/adults.aspx.  
 
Orer, G. & Guzel, N. (2014). The effects of acute l-carnitine supplementation on endurance 
performance of athletes. Journal of Strength and Conditioning Research, 28(2), 514-519. 
 
Pak-Kwong, C., Yanan, Z., Jing-Dong, L. & Binh Quach, J. (2015). A brief note on the validity 
and reliability of the rating of perceived exertion scale in monitoring exercise intensity 
among Chinese older adults in Hong Kong. Perceptual & Motor Skills, 121(3), 805-809. 
 
Parandak, K., Arazi, H., Khoshkhahesh, F. and Nakhostin-Roohi, B. (2015). The Effect of Two-
Week L-Carnitine Supplementation on Exercise -Induced Oxidative Stress and Muscle 
Damage. Asian Journal of Sports Medicine, 6(2), 123-128. 
 
Rebouche, C., Shils, M., Olson, J., Shike, M. & Ross, A. (1999). Carnitine. In Modern Nutrition 
in Health and Disease. 9th ed. Philadelphia: Lippincott, Williams & Wilkins, 505-512.  
 
Ringseis, R., Keller, J., & Eder, J. (2012). Role of carnitine in the regulation of glucose 
homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with 
carnitine supplementation and carnitine deficiency. European Journal of Nutrition, 51, 1–
18.  
 
Sahlin, K. (2011). Boosting fat burning with carnitine: an old friend comes out from the shadow. 
Journal of Physiology, 589 (7), 1509–1510.  
 
Shannon, C.E., Nixon, A.V., Greenhaff, P.L., & Stephens, F.B. (2016). Protein ingestion acutely 
inhibits insulin-stimulated muscle carnitine uptake in healthy young men. American 
Journal of Clinical Nutrition, 103 (1), 276-282.  
 
Sheel, A.W., Richards, J.C., Foster, G.E., & Guenette, J.A. (2004). Sex differences in respiratory 
exercise physiology. Journal of Sports Medicine, 34(9), 567-579.  
 
Spiering, B., Kraemer, W., Vingren, J., Hatfield, D., Fragala, M., Ho, J., Maresh, C., Anderson, 
J., & Volek, J. (2007). Responses of criterion variables to different supplemental doses of 
l-carnitine l-tartrate. Journal of Strength and Conditioning Research, 21(1), 259-264.  
 
Stamford, B. (1976). Validity and reliability of subjective ratings of perceived exertion during 
work. Journal of the Chartered Institute for Ergonomics and Human Factors, 19(1), 53-
60. 
 
Stephens, F., Constantin-Teodosiu, D., & Greenhaff, P. (2007). New insights concerning the role 
of carnitine in the regulation of fuel metabolism in the skeletal muscle. Journal of 
Physiology, 58(2), 431- 444.   
  
54 
 
Stephens, F., Wall, B., Marimuthu, K., Shannon, C., Constantin-Teodosiu, D., Macdonald, I., & 
Greenhaff, P. (2013). Skeletal muscle carnitine loading increases energy expenditure, 
modulates fuel metabolism gene networks and prevents body fat accumulation in humans. 
Journal of Physiology, 591(Pt 18), 4655-4666. 
 
Swart, B., Rossouw, J., Loots, J., Kruger, M. (1997). The effect of L-carnitine supplementation 
on plasma carnitine levels and various performance parameters of male marathon athletes. 
Nutrition Research, 17(3), 405-414.  
 
Tanner, D.A., Duke, J.W., & Stager, J.M. (2014). Ventilatory patterns differ between maximal 
running and cycling. Journal of Respiratory Physiology & Neurology, 191, 9-16. 
 
Tetyana. (2012). A study without a control group? Evidence for enhanced cognitive behavioral 
therapy for adults with anorexia nervosa. Retrieved from 
http://www.scienceofeds.org/2012/11/03/is-there-evidence-for-enhanced-cbt-for-adults-
with-a/.  
 
Tsampoukos, A., Peckham, E., James, R., & Nevill, M. (2010). Effect of menstrual cycle phase 
on sprinting performance. European Journal of Applied Physiology, 109, 659-667.  
 
Tucker, L., Lecheminant, J., & Bailey, B. (2014). Test-retest reliability of the bod pod: The 
effect of multiple assessment. Perceptual & Motor Skills, 118(2), 563-570. 
 
Ubukata, H & Matsumura, A. (2015). Relationship between the phases of the menstrual cycle 
and the transverse abdominis muscle. Journal of Physical Therapy Science, 27, 563-565. 
 
Vecchiet, L., Di Lisa, F., Pieralisi, G., Ripari, P., Menabo, R., & Siliprand, N. (1990). Influence 
of L-carnitine administration on maximal physical exercise. European Journal of Applied 
Physiology, 61(5), 486 – 490.  
 
Wall, B., Stephens, F., Constantin-Teodosiu, D., Marimuthu, K., Macdonald, I., & Greenhaff, P. 
(2011). Chronic oral ingestion of l-carnitine and carbohydrate increases muscle carnitine 
content and alters muscle fuel metabolism during exercise in humans. Journal of 
Physiology, 589(Pt 4), 963–973. http://doi.org/10.1113/jphysiol.2010.201343. 
 
Wutske, K.D. & Lorenz, H. (2004). The effect of L-carnitine on fat oxidation, protein turnover, 
and body composition in slightly overweight subjects. Journal of Metabolism, 53(8), 
1002-1006.  
 
Wyas, V., Ganzit, G.P., Riezi, A. (1990). The effects of L-carnitine administration on VO2 max  
  
55 
and the aerobic-anaerobic threshold in normoxia and acute hypoxia. European Journal of 
Applied Physiology, 54, 131 – 135.  
 
 
Yu, C., Chuan-ji, H., Chen-jing, W., Hua-shi, G., & Huan-ting, L. (2011). Single dose of L- 
carnitine improves antioxidant activities in healthy subjects. Journal of Experimental 
Medicine, 224, 209-213. 
 
 
 
 
